tbuckley/cabot-search huggingface dataset:
Cranberry for Prevention of Urinary Tract Infection?
Authors: Lindsay E. Nicolle
Journal: JAMA (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Data Sharing — Is the Juice Worth the Squeeze?
Authors: Brian L. Strom, Marc E. Buyse, John Hughes, Bartha M. Knoppers
Journal: New England Journal of Medicine (2016)

Making clinical trial data widely available is ethically imperative and scientifically justified, but the experience with clinicalstudydatarequest.com suggests that we need to find ways to improve the use and output of data-sharing projects before broadening the effort.
Days Spent at Home — A Patient-Centered Goal and Outcome
Authors: Adam C. Groff, Carrie H. Colla, Thomas H. Lee
Journal: New England Journal of Medicine (2016)

Interview with Dr. Thomas Lee on measures of health care quality that are most important to patients. (08:53)Download If “high-value, patient-centered care” is to be more than rhetoric, health care organizations need to measure outcomes that matter to patients, such as days spent at home in the last 6 months of life. There is substantial variation in this patient-centered outcome.
Impact of CD3/T Regs Ratio in Donor Graft On Survival Rates in Allogeneic Peripheral Blood Stem Cell Transplantation
Authors: Mario Delia, Domenico Pastore, Anna Mestice, Paola Carluccio, Tommasina Perrone, Francesco Gaudio, Paola Curci, Alessandra Ricco, Antonella Russo Rossi, Annamaria Giordano, Vera Carluccio, Ilaria Di Tardo, Rosa Angarano, Maria Chiara Longo, Giorgina Specchia
Journal: Blood (2012)
F<scp>ifty</scp> Y<scp>ears</scp> <scp>of</scp> R<scp>esearch</scp> <scp>in</scp> ARDS Why Is Acute Respiratory Distress Syndrome So Important for Critical Care?
Authors: Luciano Gattinoni, Michael Quintel
Journal: American Journal of Respiratory and Critical Care Medicine (2016)
TCT-664 Comparison of General versus Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): A Meta-analysis
Authors: Pedro Villablanca, Mohammed Makkiya, Katarina Nikolic, Kaijun Wang, Agata Leśniak-Sobelga, John Augoustides, Yasdet Maldonato, Harish Ramakrishna
Journal: Journal of the American College of Cardiology (2016)
P0077 : Improvement of liver elasticity in HCV-patients under sofosbuvir-based therapy after liver transplantation
Authors: L.L. Seifert, E. Vorona, C. Bester, S. Beckebaum, I. Kabar, P. Baier, A. Hüsing, M. Stahl, V. Cicinnati, H.H.-J. Schmidt
Journal: Journal of Hepatology (2015)
EFECTIVIDAD DE DOS MÉTODOS PARA PREVENCIÓN DE PANCREATITIS AGUDA POSTCPRE, ANÁLISIS EN NUESTRO MEDIO
Authors: C Martos Plasencia, R Salmoral Luque, M Sanchez Alonso, E De La Santa Belda, B López Viedma, F Domper Bardají, R Lorente Poyatos, J Olmedo Camacho
Journal: Endoscopy (2016)

La pancreatitis aguda es una de las complicaciones más frecuentes derivada de la manipulación de la vía biliar y pancreática durante una CPRE. En los últimos años las guías de practica clínica han propuesto diversos métodos para su prevención en el entorno de esta técnica. La utilización de indometacina rectal y prótesis pancreáticas plásticas son los métodos habitualmente utilizados para prevención de esta complicación. Proponemos un análisis de los resultados obtenidos con ambos en nuestro medio.
Problems Associated With Use of Mobile Devices in the Sleep Environment—Streaming Instead of Dreaming
Authors: Charles A. Czeisler, Theresa L. Shanahan
Journal: JAMA Pediatrics (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
TCT-758 Long-Term Outcomes following TAVI in patients with severe aortic stenosis and a reduced left ventricular Ejection Fraction – a single-center experience in 2.000 patients (TAVIK Register)
Authors: Gerhard Schymik, Valentin Herzberger, Jens Bergmann, Lars Conzelmann, Alexander Würth, Peter Bramlage, Armin Luik, Bernd-Dieter Gonska, Uwe Mehlhorn, Claus Schmitt, Panagiotis Tzamalis
Journal: Journal of the American College of Cardiology (2016)
Paediatricians vote for college to continue accepting funds from infant formula companies
Authors: Jacqui Thornton
Journal: BMJ (2016)

The Royal College of Paediatrics and Child Health (RCPCH) has rejected calls from its membership to stop accepting funding from formula milk companies.

Instead, it will continue to allow funding under clearly pre-specified conditions with a rigorous and robust set of safeguards in place, which it said the majority of its members had supported in a consultation. The council of the college announced the decision along with the results of the consultation, which had a 16% response rate (2522.)

In the consultation 650 paediatricians voted that the RCPCH should not accept any funding from companies that market or manufacture specialist milk formula, but 698 said that it should accept such funding after due diligence. Another 1083 said that it should accept funding with due diligence and further safeguards.

The college said in a statement, “RCPCH consulted its members on its relationships with formula milk companies (FMCs). The majority …
MINI01.08: Disparities in the Management of Patients with Stage I Small Cell Lung Cancer (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis
Authors: Zaheer Ahmed, Lara Kujtan, Sashidhar Manthravadi, Kevin F. Kennedy, John R. Davis, Janakiraman Subramanian
Journal: Journal of Thoracic Oncology (2016)
TCT-799 Comparison of Ultrasound Guided Femoral Retrograde Versus Antegrade Access Among Patients Undergoing Peripheral Arterial Interventions
Authors: Jihad Mustapha, Michael Jaff, George Adams, Larry Diaz, Robert Beasley, Sara Finton, Theresa McGoff, Carmen Heaney, Larry Miller, Fadi Saab
Journal: Journal of the American College of Cardiology (2016)
Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (<scp>LIVE</scp>)—a multicentre, double‐blind, randomised, placebo‐controlled trial
Authors: Anders Jorsal, Caroline Kistorp, Pernille Holmager, Rasmus Stilling Tougaard, Roni Nielsen, Anja Hänselmann, Brian Nilsson, Jacob Eifer Møller, Jakob Hjort, Jon Rasmussen, Trine Welløv Boesgaard, Morten Schou, Lars Videbæk, Ida Gustafsson, Allan Flyvbjerg, Henrik Wiggers, Lise Tarnow
Journal: European Journal of Heart Failure (2016)
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents
Authors: Philippe Garot, Marie-Claude Morice, Damras Tresukosol, Stuart J. Pocock, Ian T. Meredith, Alexandre Abizaid, Didier Carrié, Christoph Naber, Andres Iñiguez, Suneel Talwar, Ian B.A. Menown, Evald H. Christiansen, John Gregson, Samuel Copt, Thomas Hovasse, Philipp Lurz, Luc Maillard, Florian Krackhardt, Paul Ong, Jonathan Byrne, Simon Redwood, Ute Windhövel, Samantha Greene, Hans-Peter Stoll, Philip Urban, Philip Urban, Marie-Claude Morice, Alexander Abizaid, Ian T. Meredith, Stuart J. Pocock, Didier Carrié, Christoph Naber, Samantha Greene, Hans-Peter Stoll
Journal: Journal of the American College of Cardiology (2016)

A 1-year follow-up, polymer-free metallic stent coated with biolimus-A9 followed by 1-month dual antiplatelet therapy is safer and more effective than a bare-metal stent (BMS) for patients with high risk of bleeding.This study analyzed 2-year outcomes to determine whether these benefits are maintained.In a prospective, multicenter, double-blind trial, we randomized 2,466 high bleeding risk patients to receive a drug-coated stent (DCS) or a BMS followed by 1-month dual antiplatelet therapy. The primary safety endpoint was a composite of cardiac death, myocardial infarction, or stent thrombosis. The primary efficacy endpoint was clinically driven target lesion revascularization.At 2 years, the primary safety endpoint had occurred in 147 DCS and 180 BMS patients (15.3%) (hazard ratio: 0.80; 95% confidence interval: 0.64 to 0.99; p = 0.039). Clinically driven target lesion revascularization occurred for 77 DCS and 136 BMS patients (12.0%) (hazard ratio: 0.54; 95% confidence interval: 0.41 to 0.72; p < 0.0001). Major bleeding occurred in 8.9% of DCS and 9.2% of BMS patients (p = 0.95), and a coronary thrombotic event (myocardial infarction and/or stent thrombosis) occurred in 8.2% of DCS and 10.6% of BMS patients (p = 0.045). One-year mortality was 27.1% for a major bleed and 26.3% for a thrombotic event. At 2 years, multivariate correlates of major bleeding were age >75 years, anemia, raised plasma creatinine, and planned long-term anticoagulation. Correlates of the primary safety endpoint were age, anemia, congestive heart failure, multivessel disease, number of stents implanted, and use of a BMS rather than a DCS.Safety and efficacy benefits of DCS over BMS were maintained for 2 years in high bleeding risk patients. Rates of major bleeding and coronary thrombotic events were no different and were associated with a substantial and comparable mortality risk. (A Prospective Randomized Comparison of the BioFreedom Biolimus A9 Drug Coated Stent Versus the Gazelle Bare Metal Stent in Patients With High Risk of Bleeding [LEADERS FREE]; NCT01623180).
Circulating Endothelial Cells Enumeration Is a Helpful Tool In The Diagnosis Of GvHD In Patients Undergoing Allogeneic Hematopoietic Stem Cells Transplantation
Authors: Camillo Almici, Cristina Skert, Rosanna Verardi, Andrea Di Palma, Andrea Bianchetti, Domenico Russo, Mirella Marini
Journal: Blood (2013)
P3.02c-050 IMpower010: Phase III Study of Atezolizumab vs BSC after Adjuvant Chemotherapy in Patients with Completely Resected NSCLC
Authors: Heather Wakelee, Nasser Altorki, Eric Vallieres, Caicun Zhou, Yunxia Zuo, Michael Howland, Fan Xia, Tien Hoang, Alan Sandler, Enriqueta Felip
Journal: Journal of Thoracic Oncology (2017)
Protein Kinase Cδ Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity
Authors: Dongshan Zhang, Jian Pan, Xudong Xiang, Yu Liu, Guie Dong, Man J. Livingston, Jian-Kang Chen, Xiao-Ming Yin, Zheng Dong
Journal: Journal of the American Society of Nephrology (2016)

Nephrotoxicity is a major adverse effect in cisplatin chemotherapy, and renoprotective approaches are unavailable. Recent work unveiled a critical role of protein kinase C δ (PKC δ ) in cisplatin nephrotoxicity and further demonstrated that inhibition of PKC δ not only protects kidneys but enhances the chemotherapeutic effect of cisplatin in tumors; however, the underlying mechanisms remain elusive. Here, we show that cisplatin induced rapid activation of autophagy in cultured kidney tubular cells and in the kidneys of injected mice. Cisplatin also induced the phosphorylation of mammalian target of rapamycin (mTOR), p70S6 kinase downstream of mTOR, and serine/threonine-protein kinase ULK1, a component of the autophagy initiating complex. In vitro , pharmacologic inhibition of mTOR, directly or through inhibition of AKT, enhanced autophagy after cisplatin treatment. Notably, in both cells and kidneys, blockade of PKC δ suppressed the cisplatin-induced phosphorylation of AKT, mTOR, p70S6 kinase, and ULK1 resulting in upregulation of autophagy. Furthermore, constitutively active and inactive forms of PKC δ respectively enhanced and suppressed cisplatin-induced apoptosis in cultured cells. In mechanistic studies, we showed coimmunoprecipitation of PKC δ and AKT from lysates of cisplatin-treated cells and direct phosphorylation of AKT at serine-473 by PKC δ in vitro . Finally, administration of the PKC δ inhibitor rottlerin with cisplatin protected against cisplatin nephrotoxicity in wild-type mice, but not in renal autophagy–deficient mice. Together, these results reveal a pathway consisting of PKC δ , AKT, mTOR, and ULK1 that inhibits autophagy in cisplatin nephrotoxicity. PKC δ mediates cisplatin nephrotoxicity at least in part by suppressing autophagy, and accordingly, PKC δ inhibition protects kidneys by upregulating autophagy.
Abstract #2868: Thymidine Kinase 1, a molecular target for immunotherapy is overexpressed in the plasma membrane of lymphoma cells
Authors: Jaden Evans, Melissa Tovar, Samuel Brady, Byron Murray, Richard Robison, Kim O'Neill
Journal: Cancer Research (2009)

Thymidine Kinase 1 (TK1), an important nucleotide salvage pathway enzyme, has been shown to be upregulated in most malignant cancers. Recent studies have shown this essential enzyme not only has diagnostic and prognostic value, but TK1 could also be used as a molecular target for therapeutic treatments. TK1 has been shown to be a possible molecular target for neutron capture therapy in brain tumors. Other studies have explored the potential of TK1 as a therapeutic target in many solid tumors, including breast, colon, and prostate. This particular study provides insight on the reality of TK1 as a therapeutic target in lymphoma. This insight was provided by analyzing the localization of TK1 in lymphoblastoid cells derived from Burkitt\#8217;s lymphoma (Raji cells). The cells were lysed and the membranes were separated by centrifugation. The membranes were then fractionated further, using sucrose density gradient ultracentrifugation, in order to discriminate the inner membranes from the plasma membranes. Healthy, normal lymphocytes were lysed and fractionated simultaneously as a negative control. The plasma membranes and inner membranes of each specimen were collected and the samples were assayed for TK1 activity using the TK radioassay. This assay was run with both ATP and CTP in order to calculate relative percentage values of both human isoforms: TK1 and TK2. The preliminary results showed TK1 99% of enzyme activity expressed in the plasma membrane of healthy lymphocytes. In contrast, results from the plasma membrane of the Raji cells showed TK1>60% and TK2  Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 2868.
P0576 : Impact of organ and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis D virus infection
Authors: K. Zachou, C. Yurdaydin, U. Drebber, V. Schlaphoff, H.P. Dienes, M.P. Manns, H. Wedemeyer, G.N. Dalekos
Journal: Journal of Hepatology (2015)
A Short Key to Both Sexes of the Anopheline Species of India, Ceylon and Malaya.
Journal: JAMA (1925)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
TCT-693 Four-Year Clinical Outcomes Following TAVR with the Repositionable and Fully Retrievable Lotus Valve System: an Update from the REPRISE I Study
Authors: Ian Meredith, Stephen Worthley, Robert Whitbourn, Joseph Montarello, Andrew Newcomb, Dominic J. Allocco, Keith D. Dawkins, MaryEllen Klusacek
Journal: Journal of the American College of Cardiology (2016)
TCT-27 Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-implant Antithrombotic Therapy
Authors: Kasper Korsholm, Kirsten Melgaard Nielsen, Jesper Møller Jensen, Henrik Kjærulf Jensen, Grethe Andersen, Jens Erik Nielsen-Kudsk
Journal: Journal of the American College of Cardiology (2016)
Preliminary Results of a Pilot Trial of Unrelated Umbilical Cord Blood Transplantation (UCBT) Augmented with Cytokine-Primed Aldehyde Dehydrogenase-Bright (ALDHbr) Cells.
Authors: Joanne Kurtzberg, Andrew Balber, Adam Mendizabal, Melissa Reese, Ann Kaestner, Tracy Gentry, Darren Hickerson, Colleen Allen, Linda S. Sledge, Erica Deibert, June Allison, Jennifer Baker, N. Rebecca Haley
Journal: Blood (2006)
TCT-482 First generation drug-eluting stent is worse than contemporary bare metal stent after long-term follow-up: A report from SCAAR
Authors: Sebastian Volz, Christian Dworeck, Oscar Angeras, Inger Haraldsson, Dan Ioanes, Jacob Odenstedt, Petur Petursson, Lotta Robertsson, Jason Stewart, Magnus Wahlin, Per Albertsson, Truls Råmunddal, Elmir Omerovic
Journal: Journal of the American College of Cardiology (2016)
Patient satisfaction with GPs is not related to consultation length, study finds
Authors: Susan Mayor
Journal: BMJ (2016)

Patients’ self reported satisfaction with GPs’ communication and their confidence and trust in a GP consultation are not related to the length of the appointment, a UK study has found.1

Longer consultations in primary care have been associated with better quality of care and improved health related outcomes, but evidence of any link between consultation length and patient experience is limited.

Researchers investigated the relation between consultation length, patient reported levels of communication, and their trust and confidence …
Brief Report: Management of Chronic Post‐Chikungunya Rheumatic Disease: The Martinican Experience
Authors: Marie Blettery, Lauren Brunier, Kathleen Polomat, Florence Moinet, Christophe Deligny, Serge Arfi, Georges Jean‐Baptiste, Michel De Bandt
Journal: Arthritis & Rheumatology (2016)

To describe chronic chikungunya manifestations seen during the outbreak in the Caribbean from December 2013 to January 2015.Patients were seen at our center, the only rheumatology department in Martinique Island, and were examined by a senior rheumatologist using a standard care report form. Chikungunya was diagnosed collectively based on consensus among all clinicians. The median time from onset of acute chikungunya to the first rheumatology consultation was calculated, severity was evaluated based on clinical scales and the degree of joint destruction, and each patient's treatment was recorded.For the 147 patients analyzed, the median time between onset of acute chikungunya and the first rheumatology consultation was 8 months. After review of each patient's medical record, 19 (12.9%) were diagnosed as having epidemic-influenced chikungunya. Four distinct rheumatologic patterns were observed in the remaining patients (those with compatible history and positive serologic findings): 47 patients (32%) had reactivation of painful chronic mechanical manifestations, 9 patients (6.1%) had fibromyalgia, 45 patients (30.6%) met criteria for spondyloarthritis (as evaluated before the chikungunya virus infection in all patients) and experienced a flare, and 27 patients (18.4%), with no history of joint disease, developed de novo bilateral symmetric chronic inflammatory joint disease in response to chikungunya virus infection. For inflammatory arthritis, most patients were treated with methotrexate (up to 25 mg/week), with good response and tolerance. Thirteen patients were treated with conventional doses of anti-tumor necrosis factor agents, with good tolerance and efficacy as expected.The term "chronic chikungunya syndrome" covers multiple etiologies. Compliance with the French Society of Rheumatology recommendations, careful recording of patient histories, and serologic verification help prevent errors inherent to the epidemic context and ensure early therapeutic intervention for these patients. To avoid late initiation of treatment, patients should receive rheumatologic consultation as early as possible.
<scp>T</scp>hrombotic issues in transgender medicine: A review
Authors: Joseph J. Shatzel, Kara J. Connelly, Thomas G. DeLoughery
Journal: American Journal of Hematology (2016)

Clinicians, including hematologists, are more frequently encountering transgender individuals in practice; however, most lack training on the management and complications of transgender medicine. Hormonal therapy forms the backbone of medical interventions for patients undergoing gender transition. While supplementing an individual's intrinsic sex hormone is associated with a variety of hematologic complications including increased rates of venous thrombosis, cardiovascular events, erthyrocytosis, and malignancy, the risks of supplementing with opposing sex hormones are not well understood. Data on the hematologic complications of these therapies are accumulating but remain limited, and clinicians have little experience with their management. This review highlights the current interventions available in transgender medicine and related potential hematologic complications, and it suggests simple, evidence-based management going forward. Am. J. Hematol. 92:204-208, 2017. © 2016 Wiley Periodicals, Inc.
TRATAMIENTO DE LAS DEHISCENCIAS DE ANASTOMOSIS ESOFAYOYEYUNALES CON PRÓTESIS POR VÍA ENDOSCÓPICA: REVISIÓN DE CASOS EN NUESTRO CENTRO
Authors: M Curieses Luengo, E Barreiro Alonso, M Izquierdo Romero, JM Perez Pariente, A Alvarez Alvarez, R Tojo Gonzalez, M Pipa Muñiz, I Perez Valle, FJ Román Llorente
Journal: Endoscopy (2016)

Introducción: La mortalidad de las dehiscencias de anastomosis esofagoyeyunales tras una gastrectomía total es muy elevada, mayor del 40% en algunas series. Las prótesis metálicas recubiertas están siendo usadas como alterativa a la reintervención quirúrgica con aceptables resultados.